Conflicts of interest: None declared.
Body mass index and acute ischemic stroke outcomes
Article first published online: 22 OCT 2013
© 2013 The Authors. International Journal of Stroke © 2013 World Stroke Organization
International Journal of Stroke
Volume 9, Issue 5, pages 618–623, July 2014
How to Cite
Saini, M., Saqqur, M., Shuaib, A. and VISTA Collaborators (2014), Body mass index and acute ischemic stroke outcomes. International Journal of Stroke, 9: 618–623. doi: 10.1111/ijs.12168
- Issue published online: 9 JUN 2014
- Article first published online: 22 OCT 2013
- Manuscript Accepted: 12 JUN 2013
- Manuscript Received: 9 MAR 2013
- body mass index;
The impact of body mass index on acute ischemic stroke outcomes is unclear.
Aims and/or hypothesis
We sought to determine the effect of body mass index on short-term (90 days) acute ischemic stroke outcomes.
Data were extracted for patients with acute ischemic stroke and records of body mass index at baseline from the Virtual International Stroke Trials Archive database. Multivariate logistic regression and Cox proportional hazard analysis were used to analyze effect of body mass index on poor functional outcome (modified Rankin Scale >2) and mortality, respectively, within 90 days of stroke's onset.
Of the 4811 patients (mean age 68·8 ± 12·2 years) included in the study, 2002 (41·6%) were overweight, and 1095 (22·8%) were obese. Overweight (body mass index 25–29·9 kg/m2) was associated with decreased mortality (hazard ratios 0·59; 95% confidence interval 0·51–0·68; P < 0·01) and decrease in poor functional outcome (odds ratio 0·74; 95% confidence interval 0·64–0·85; P < 0·01) following acute ischemic stroke. The association of body mass index with stroke outcomes was dependent on age, gender, and use of thrombolytic therapy.
Being overweight or obese is associated with a better functional outcome and reduced mortality in patients of acute ischemic stroke. However, the definition of an ‘optimal’ body mass index, in relation to stroke outcomes, may be affected by age, gender, and use of thrombolytic therapy.